TORONTO, Sept. 12, 2012 /CNW/ - Patheon Inc. (TSX: PTI), a leading
provider of contract development and manufacturing services to the
global pharmaceutical industry, announced today that it has appointed
Harry Gill to the position of Senior Vice President, Quality and
James C. Mullen, Patheon's Chief Executive Officer said, "I am impressed
with Harry's vision for embedding a quality mindset, his insights into
our operations, and his focus on operational improvements to drive
performance and improve the customer experience."
Harry joined Patheon in 2010. He has over 25 years' experience in
quality, plant operations, technical services and operational
Patheon Inc. (TSX: PTI) is a leading global provider of contract
development and manufacturing services to the global pharmaceutical
industry. The company provides the highest quality products and
services to approximately 300 of the world's leading pharmaceutical and
biotechnology companies. Its services range from preclinical
development through commercial manufacturing of a full array of dosage
forms including parenteral, soft gel, solid and liquid forms.
The company's comprehensive range of fully integrated Pharmaceutical
Development Services includes pre-formulation, formulation, analytical
development, clinical manufacturing, scale-up and commercialization.
The company's integrated development and manufacturing network of 10
manufacturing facilities and nine development centers across North
America and Europe, enables customer products to be launched with
confidence anywhere in the world.
SOURCE: Patheon Inc.
For further information:
Investor Relations and Corporate Communications
Tel: (919) 226-3313